Search

Dipenkumar Modi, Principal Investigator

National Cancer Institute (NCI) and Genta Incorporated

National Cancer Institute (NCI)

Nanjing Enricnk Biotech Co., Ltd

Peng Liu, Professor

Peng Liu, Professor

Takeda and Marcel Nijland, Hematologist

CSPC Ouyi Pharmaceutical Co., Ltd. and Ou Bai, MD/PHD, Director

Celgene

Amgen

Bayer

National Cancer Institute (NCI), ADC Therapeutics S.A., and Joseph Tuscano, Principal Investigator

Wuhan Union Hospital, China, Ningbo No. 1 Hospital, National Naval Medical Center, Shanghai Fengxian District Central Hospital, YANCHENG NO.1 PEOPLE'S HOSPITAL, The First Affiliated Hospital of Nanchang University, Affiliated Hospital of Nantong University, Wuxi Branch of Ruijin Hospital, Sir Run Run Shaw Hospital, Northern Jiangsu People's Hospital, The First People's Hospital of Changde City, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Changzhou No.2 People's Hospital, The Affiliated Hospital of Xuzhou Medical University, Huai'an First People's Hospital, Taizhou Hospital, The First People's Hospital of Kunshan, First Affiliated Hospital of Fujian Medical University, Huadong Hospital, Henan Provincial People's Hospital, First Hospital of China Medical University, Shandong Provincial Hospital, HARBIN THE FIRST HOSPITAL, The First Hospital of Jilin University, Hunan Cancer Hospital, Qilu Hospital of Shandong University, THE FIRST AFFILIATED HOSPITAL, The Second Affiliated Hospital of Dalian Medical University, SUZHOU HONGCI HEMATOLOGY HOSPITAL, and Zhao Weili, First Deputy Director, Hematology Department

Zhihua Yao, PhD, Director

Novartis and Ohio State University Comprehensive Cancer Center

Mark Roschewski, M.D., Principal Investigator

National Cancer Institute (NCI)

University of Leipzig, University Hospital Regensburg, Wuerzburg University Hospital, University Hospital of Gießen and Marburg, Saarland University Medical Center, and AstraZeneca

The First Affiliated Hospital of Nanchang University and Zengjun Li, Head of the Hematology Department

Shanghai AbelZeta Ltd. and Zou Dehui, Chief Physician

Zhao Weili, Professor

Associazione Italiana per la Ricerca sul Cancro, IRCCS Azienda Ospedaliero-Universitaria di Bologna, and Pier Luigi Zinzani, Full Professor of Hematology

Yao Liu, Chief physician

cimiez hospital Nice, Institut Bergonié, groupe hospitalier public sud de l'oise, Henri Mondor University Hospital, Centre Henri Becquerel, Hôpital Charles Foix, and Saint-Louis Hospital, Paris, France

National Cancer Institute (NCI)

Merck Sharp & Dohme LLC

Quebec Clinical Research Organization in Cancer, Novartis, Hoffmann-La Roche, and Sarit Assouline, Physician, Division of Hematology, Jewish General Hospital. Assistant Professor, Department of Oncology, McGill University